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A NEW THERAPEUTIC CONCEPT FOR LONG-LASTING 
IATROGENIC PRIAPISM: A CASE REPORT 
H. FREYMANN, M. DJ AMILIAN, W. F. THON, C. G. S T I E F A N D U. JONAS 
From the Department of Urology, Medical School Hannover, Hannover, Germany 
ABSTRACT 
In a therapeutic attempt on an 18-year-old patient with iatrogenic priapism lasting for more than 
2 weeks after internal urethrotomy, intracavernous lysis was commenced with 80,000 IU streptoki­
nase per hour. Following a dosage of 300,000 IU streptokinase the lysis was stopped because of 
severe bleeding from the urethrotomy scar. At 4 weeks after the patient was discharged from the 
hospital he reported normal erections and intercourse, while single potential analysis of cavernous 
electrical activity and ultrasound returned to normal. Provided there are no contraindications, 
intracavernous lysis seems to be an effective treatment for long-lasting priapism induced by 
intracavernous thrombosis. 
K E Y WORDS: priapism, streptokinase, penile erection, thrombosis 
Currently, priapism is mostly seen after intracavernous in­
jections of vasoactive drugs in the diagnosis and therapy of 
male erectile dysfunction.1 Various other reasons for this syn­
drome are known, including primary priapism (idiopathic or 
after prolonged sexual excitement) and secondary priapism 
(hematological diseases, neurological dysfunctions, local disor­
ders and pharmacological agents).2 Postoperative priapism is a 
rare but severe complication of various urological and other 
iatrogenic manipulations.3 The diagnosis is made by clinical 
evaluation. Differentiation between high flow and low flow 
priapism can be made by Doppler sonography. The nervous 
dysfunction is demonstrated by single potential analysis of 
cavernous electrical activity with electrical anodes applied to 
the penis, and registered and analyzed by a neurophysiological 
measuring instrument. 
Early intervention is of prime importance in the treatment 
of all forms of priapism. Therapeutic trials performed after 24 
hours are mostly of limited success because of thrombosis and 
fibrosis of the corpora cavernosa.4 The initial therapy admin­
istered is aspiration of intracavernous blood and/or intracav­
ernous injection of an α-adrenoreceptor agonist, such as 
metaraminol (2 to 4 mg.).5,6 In case of failure, a shunt procedure7"9 
is done, or in the case of arterial high inflow priapism selective 
temporary embolization of the pudendal arteries with auto­
logous clots may follow.1 0 In regard to long-term results, many 
patients with priapism are permanently impotent. In this case 
the only therapeutic option is placement of a semirigid or 
malleable penile prosthesis, which imposes difficulties in the 
operative management due to cavernous fibrosis.11 
C A S E R E P O R T 
Iatrogenic priapism occurred in an 18-year-old patient after 
internal urethrotomy for urethral stricture due to catheteriza­
tion during a cardiac operation 13 years ago. At 2 weeks 
following urethrotomy the patient was referred to our hospital 
for priapism, which had begun 14 days previously. At clinical 
evaluation the penis was still erect but painless. On palpation 
it was not entirely rigid but the consistency of the corporeal 
bodies was dramatically increased even though the glans was 
soft. 
Doppler ultrasound of the penile arteries showed strong 
cavernous artery pulses bilaterally but decreased inflow veloc­
ity. Ultrasound showed increased density of the cavernous 
tissue (fig. 1) and single potential analysis of cavernous electri­
cal activity revealed significantly decreased cavernous electrical 
activity.1 2 Two attempts involving aspiration of the cavernous 
Accepted for publication February 14, 1992. 
blood (2 times 200 ml.), which appeared glutinous and cyanotic, 
followed by intracavernous injection of 0.4 mg. phenylephrine 
and then 4 mg. metaraminol induced no detumescence. 
Since cavernous thrombosis could be assumed by ultrasound, 
single potential analysis of cavernous electrical activity and 
clinical evaluation, intracavernous lysis with streptokinase was 
attempted. Lysis was begun with 80,000 IU per hour strepto­
kinase perfused intracavernously via 2 butterfly cannulas bilat­
erally under cardiovascular monitoring to attain the maximal 
dosage of 500,000 IU streptokinase. A dosage of only 300,000 
IU streptokinase could be injected due to severe bleeding from 
the urethrotomy scar. There was a marked decrease in rigidity 
while under therapy. 
Single potential analysis of cavernous electrical activity 7 
days later showed improved cavernous activity and ultrasound 
revealed clear diminution of intracavernous hyperechogenicity 
(fig. 2). At 4 weeks after he was discharged from the hospital 
the patient reported normal erections and intercourse. Clinical 
evaluation revealed the corpora cavernosa to be soft. No devia­
tion or fibrosis was palpable, and single potential analysis of 
cavernous electrical activity and ultrasound findings returned 
to normal. 
FlG. 1. Ultrasonography of corpora cavernosa with thrombosis and 
beginning of fibrosis before therapy. 
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F I G . 2. Ultrasonography of corpora cavernosa 7 days after intracav-
ernous lysis. Note obvious decrease of intracavernous echo reflections. 
D I S C U S S I O N 
After transurethral manipulations, a blood stasis or low flow 
priapism can occur by nervous dysfunction caused by anes-
thesia, urethral injury or spinal cord disorders while the causal 
mechanism is not clear. This may be assumed as a nervous 
dysfunction of smooth muscle fibers in the corpora cavernosa. 
It is not clear if the transformation of cavernous smooth muscle 
cells to fibroblast-like cells is the cause or a consequence of the 
priapism.1 3 The nervous dysfunction can be proved by single 
potential analysis of cavernous electrical activity. Blood stasis 
leads to an elevation of carbon dioxide and an increase in blood 
viscosity, with consequent edema of the cavernous tissue. 
Thrombosis and subsequent destruction of the cavernous ultra-
structures were observed.14 In case of complete fibrosis of the 
corpora cavernosa and consequent impotence, a penile prosthe-
sis seems to be the only available therapy. 
A decrease in the blood viscosity and lysis of commencing 
thrombosis may interrupt the vicious circle. In long-lasting 
priapism with commencement of fibrosis streptokinase may 
dissolve the thrombosis and lead to increased blood flow. Strep-
tokinase is a protein from ß-hemolyzing streptococci, which 
begins the human fibrinolysis by activating plasminogen to 
plasmin.15 Therefore, old wounds can start bleeding, so that in 
priapism therapy following transurethral manipulations cath-
eterization should be done. 
Patients with long-term, low flow priapism and intracaver-
nous thrombosis should undergo therapy after diagnostic pro-
cedures (Doppler sonography, single potential analysis of 
cavernous electrical activity, aspiration and analysis of intra-
cavernous blood) and exclusion of contraindications (hyper-
tonus, myocardial infarcts more than 12 hours previously, 
hemostatic diseases, recent operations until day 6 or severe 
gastrointestinal diseases). A local lysis can be done using a high 
dosage of fibrinolytic agent (500,000 IU streptokinase), per-
fused slowly with 2 butterfly cannulas intracavernously. Con-
trol of the partial thromboplastin time is inevitable during 
therapy. Side effects include bleeding, allergic reactions, in-
crease of temperature and nausea. In case of severe bleeding 
streptokinase infusion should be stopped and a proteinase 
inhibitor, synthetic antifibrinolytic agents or substitution of 
coagulation factors should be given.16 Intracavernous lysis 
seems to be an effective treatment for long-lasting priapism 
induced by intracavernous thrombosis. However, more experi-
ence in this field is required. 
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